Dr. Rana A. Youness
Dr. Anisha Veeren
Section Collection Information
Dear Colleagues,
Nanobiotechnology is a thought-provoking field of research that mainly involves the development, synthesis and optimization novel nanomaterials for diagnostic, prognostic and therapeutic purposes (theranostic purposes). Such nanoscale carriers promote the controlled, effective delivery of various therapeutic molecules via increasing endocytosis and improving tumor cellular uptake and the enhanced permeability and retention effect (EPR).
Liposomes are among the nanoscale carriers that represent a recognized and unswerving drug and gene delivery systems that are frequently employed in cancer therapy, the well-known liposomal doxorubicin (Doxil, Janssen Biotech, Inc.) represents the best example of selective tumor targeting with decreased toxicity. Moreover, several nanoparticles are now being formulated to carry molecular anti-cancer agents and vaccines. Thus, broadening the scale of nano-biotechnology in the field of oncology.
This special issue is accepting research articles, review articles and commentaries focusing on the utilization of nanoparticles in the diagnosis, prognosis and treatment of different solid and hematological malignancies
Please note: manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) are out of scope for this section and will not be accepted as part of this Research Topic.
Dr. Rana A. Youness
Section Editors